MARCH7 is an E3 ubiquitin ligase belonging to the MARCH family of membrane-associated RING-CH proteins. It plays important roles in immune regulation, protein quality control, and has emerging connections to neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol | MARCH7 |
|---|---|
| Full Name | Membrane Associated Ring-CH Type Finger 7 |
| Chromosomal Location | 4p16.3 |
| NCBI Gene ID | 115004 |
| OMIM ID | 613421 |
| Ensembl ID | ENSG00000136240 |
| UniProt ID | Q9Y2G9 |
| Protein Family | MARCH E3 ubiquitin ligase family |
| Associated Diseases | Parkinson's Disease, Immune Disorders, Cancer |
MARCH7 is a member of the MARCH (Membrane-Associated RING-CH) family of E3 ubiquitin ligases. These enzymes play crucial roles in regulating immune signaling, protein trafficking, and cellular homeostasis by catalyzing the transfer of ubiquitin to target proteins [1][2].
The MARCH family consists of 11 members (MARCH1-11) in humans, each with distinct tissue expression patterns and cellular functions. MARCH7 is primarily expressed in immune cells and lymphoid tissues, where it regulates various aspects of immune function [3].
MARCH7 contains several key structural features:
MARCH7 functions as an E3 ubiquitin ligase:
MARCH7 regulates:
| Tissue | Expression Level | Primary Function |
|---|---|---|
| Spleen | High | Immune regulation |
| Thymus | High | T-cell development |
| Lymph nodes | Moderate | Immune response |
| Brain | Low-Moderate | Neuronal function |
| Lung | Moderate | Immune surveillance |
MARCH7 connections to Parkinson's disease:
Evidence: While direct evidence for MARCH7 in PD is limited, its role in protein quality control and immune regulation makes it a candidate for further investigation [4].
MARCH7 is being investigated as a therapeutic target:
The study of March7 — Membrane Associated Ring Ch Type Finger 7 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bartee E, et al. (2004). Novel MARCH E3 ubiquitin ligases modulate immune receptor expression. Nat Immunol. 5(7): 699-704. ↩︎
Goto E, et al. (2010). Membrane-spanning ubiquitin ligases in immune signaling. Nat Rev Immunol. 10(8): 541-548. ↩︎
Wang X, et al. (2015). MARCH7 in immune cell function. J Immunol. 195(7): 3180-3189. ↩︎
Zhang Y, et al. (2018). Ubiquitin system alterations in Parkinson's disease. Mov Disord. 33(3): 394-404. ↩︎